Cross-national epidemiology of panic disorder and panic attacks in the world mental health surveys
Por:
de Jonge P, Roest AM, Lim CC, Florescu SE, Bromet EJ, Stein DJ, Harris M, Nakov V, Caldas-de-Almeida JM, Levinson D, Al-Hamzawi AO, Haro JM, Viana MC, Borges G, O'Neill S, de Girolamo G, Demyttenaere K, Gureje O, Iwata N, Lee S, Hu C, Karam A, Moskalewicz J, Kovess-Masfety V, Navarro-Mateu F, Browne MO, Piazza M, Posada-Villa J, Torres Y, Ten Have ML, Kessler RC and Scott KM
Publicada:
1 dic 2016
Ahead of Print:
24 oct 2016
Resumen:
ContextThe scarcity of cross-national reports and the changes in Diagnostic and Statistical Manual version 5 (DSM-5) regarding panic disorder (PD) and panic attacks (PAs) call for new epidemiological data on PD and PAs and its subtypes in the general population.
ObjectiveTo present representative data about the cross-national epidemiology of PD and PAs in accordance with DSM-5 definitions.
Design and settingNationally representative cross-sectional surveys using the World Health Organization Composite International Diagnostic Interview version 3.0.
ParticipantsRespondents (n = 142,949) from 25 high, middle, and lower-middle income countries across the world aged 18 years or older.
Main outcome measuresPD and presence of single and recurrent PAs.
ResultsLifetime prevalence of PAs was 13.2% (SE 0.1%). Among persons that ever had a PA, the majority had recurrent PAs (66.5%; SE 0.5%), while only 12.8% fulfilled DSM-5 criteria for PD. Recurrent PAs were associated with a subsequent onset of a variety of mental disorders (OR 2.0; 95% CI 1.8-2.2) and their course (OR 1.3; 95% CI 1.2-2.4) whereas single PAs were not (OR 1.1; 95% CI 0.9-1.3 and OR 0.7; 95% CI 0.6-0.8). Cross-national lifetime prevalence estimates were 1.7% (SE 0.0%) for PD with a median age of onset of 32 (IQR 20-47). Some 80.4% of persons with lifetime PD had a lifetime comorbid mental disorder.
ConclusionsWe extended previous epidemiological data to a cross-national context. The presence of recurrent PAs in particular is associated with subsequent onset and course of mental disorders beyond agoraphobia and PD, and might serve as a generic risk marker for psychopathology.
Filiaciones:
de Jonge P:
Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Roest AM:
Department of Psychiatry, Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
Lim CC:
Department of Psychological Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand
Florescu SE:
National School of Public Health, Management and Professional Development, Bucharest, Romania
Bromet EJ:
Department of Psychiatry, Stony Brook University School of Medicine, Stony Brook, New York, USA
Stein DJ:
Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, Republic of South Africa
Harris M:
School of Public Health, University of Queensland, Herston, QLD, Australia
Nakov V:
Department of Mental Health, National Center of Public Health and Analyses, Sofia, Bulgaria
Caldas-de-Almeida JM:
Chronic Diseases research Center (CEDOC) and Department of Mental Health, Faculdade de Ciencias Medicas, Universidade Nova de Lisboa, Lisboa, Portugal
Levinson D:
Mental Health Services, Ministry of Health Israel, Israel
Al-Hamzawi AO:
College of Medicine, Al-Qadisiya University, Al Diwaniya City, Iraq
Haro JM:
CIBERSAM, Parc Sanitari Sant Joan de Deu, Universitat de Barcelona, Barcelona, Spain
Viana MC:
Department of Social Medicine, Federal University of Espirito Santo, Brazil
Borges G:
Instituo Nacional der Psiquiatria, Calzada Mexico Xochimilco, Mexico
O'Neill S:
School of Psychology, University of Ulster, Londonderry, UK
de Girolamo G:
IRCCS Centro S. Giovanni di Dio Fatebenefratelli, Brescia, Italy
Demyttenaere K:
Department of Psychiatry, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium
Gureje O:
Department of Psychiatry, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria
Iwata N:
Department of Psychology, Hiroshima International University, Hiroshima, Japan
Lee S:
Department of Psychiatry, The Chinese University of Hongkong, Hongkong, China
Hu C:
Institute of Mental Health, Peking University, Beijing, China
Karam A:
Institute for Development, Research, Advocacy and Applied Care (IDRAAC), Beirut, Lebanon
Moskalewicz J:
Institute of Psychiatry and Neurology, Warsaw, Poland
Kovess-Masfety V:
Ecole des Hautes Estudies en Sante Pulbique, Paris Descartes University, Paris, France
Navarro-Mateu F:
Instituto Murciano de Investigación Biosanitaria (IMIB)-Arrixaca. Centro de Investigación Biomédica en Red. Epidemiología y Salud Pública (CIBERESP)-Murcia. Subdirección General de Salud Mental y Asistencia Psiquiátrica. Servicio Murciano de Salud, El Palmar (Murcia), Spain
Browne MO:
Centre for Mental Health, Melbourne School of Population and Global Health, University of Melbourne, Australia
Piazza M:
National Institute of Health, Peru, Universidad Cayetano Hereidia, St. Martin de Porres, Peru
Posada-Villa J:
El Bosque University, Bogota, Colombia
Torres Y:
Center for Excellence on Research in Mental Health, CES University, Medellin, Colombia
Ten Have ML:
Trimbos Instituut, Netherlands Institute of Mental Health and Addiction, Utrecht, Netherlands
Kessler RC:
Department of Health Care Policy, Harvard University Medical School, Boston, MA, USA
Scott KM:
Department of Psychological Medicine, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand
Green Accepted, Green Submitted, Green Published, gold
|